This single-center, cross-sectional study retrospectively examined whether specific KIR/HLA pairs were associated with progression to liver cirrhosis, HCC development, and freedom from NUC treatment in chronic HBV patients. The gene discussed is KIR3DL1; the disease is hepatocellular carcinoma.